![Gregory Weaver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Weaver
Direttore Finanziario/CFO presso
ALTIMMUNE, INC.
Patrimonio netto: 113 120 $ in data 31/07/2026
Profilo
Gregory L.
Weaver is currently Director at BioIntelliSense, Inc., Harborpath, Inc., and Centenara Labs AG.
Mr. Weaver is also Chief Financial Officer at Altimmune, Inc. since 2024.
Formerly, Mr. Weaver was Chief Financial Officer, Director, and Executive Vice President at Atossa Therapeutics, Inc. in 2023; Chief Financial Officer at Cognito Therapeutics, Inc. from 2023 to 2024; Chief Financial Officer at Atai Beckley NV from 2020 to 2022; Member-Supervisory Board at TME Pharma NV from 2021 to 2022; Chief Financial and Accounting Officer at Eloxx Pharmaceuticals, Inc. from 2017 to 2020; Independent Director at Zyla Life Sciences LLC from 2014 to 2020; Global Chief Financial Officer and Executive Vice President at Oryzon Genomics SA from 2014 to 2015; Chief Financial Officer at Liminal BioSciences, Inc. from 2015 to 2017; CFO, Secretary, Treasurer, and Senior Vice President at Fibrocell Science, Inc. from 2013 to 2014; Chief Financial Officer and Senior Vice President at Imunon, Inc. from 2005 to 2011; Chief Financial Officer at Verity Solutions Group, Inc. from 2007 to 2008; Director at SCOLR Pharma, Inc. in 2009; Chief Financial Officer at Poniard Pharmaceuticals, Inc. in 2010; Chief Financial Officer and Senior Vice President at Sirna Therapeutics, Inc. in 2006; Chief Financial Officer at ILEX Oncology, Inc. in 2002; Chief Financial Officer at Prism Technologies, Inc. from 1996 to 1998; Chief Financial Officer at Oncology, Inc. from 1996 to 1999; and Chief Financial Officer at MDRNA, Inc. from 2002 to 2005.
Education includes undergraduate studies at Trinity University and a Master of Business Administration from Boston College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ALTIMMUNE, INC. 0,02% | 31/07/2026 | 39.831 ( 0,02% ) | 113 120 $ | 31/07/2026 |
Posizioni attive di Gregory Weaver
| Società | Posizione | Inizio |
|---|---|---|
| ALTIMMUNE, INC. | Direttore Finanziario/CFO | 11/11/2024 |
Rejuveron Life Sciences AG
 Rejuveron Life Sciences AG Investment ManagersFinance Functions as an alternative investment manager | Direttore/Membro del Consiglio | - |
BioIntelliSense, Inc.
 BioIntelliSense, Inc. Packaged SoftwareTechnology Services Develops health monitoring and clinical intelligence for remote patient monitoring | Direttore/Membro del Consiglio | 01/06/2023 |
Harborpath, Inc.
 Harborpath, Inc. Harborpath, Inc. is a national nonprofit healthcare organization that provides uninsured and vulnerable patients with free medications for conditions such as opioid overdose, cancer, and chronic diseases. The private company is based in Charlotte. The organization streamlines access to these drugs through a simplified, HIPAA-compliant application process, partners with pharmaceutical manufacturers, healthcare providers, states, and nonprofits, and supports communities affected by the opioid and fentanyl epidemic. Harborpath also conducts education campaigns, supplies naloxone to first responders and students, and offers oncology patient assistance programs. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Gregory Weaver
| Società | Posizione | Fine |
|---|---|---|
Cognito Therapeutics, Inc.
 Cognito Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with neurodegenerative diseases | Direttore Finanziario/CFO | 01/06/2024 |
| ATOSSA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 05/10/2023 |
| TME PHARMA N.V. | Direttore/Membro del Consiglio | 30/09/2022 |
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Direttore Finanziario/CFO | 16/08/2022 |
| ELOXX PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 15/03/2020 |
Formazione di Gregory Weaver
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
25
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 25 |
|---|---|
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services Researches, develops, manufactures and commercializes nasally administered forms of pharmaceuticals | Commercial Services |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
Trinity University
 Trinity University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel prescription pharmaceutical, over-the-counter and nutritional products | Health Technology |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic technology for agricultural and medical applications | Commercial Services |
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Prism Technologies, Inc.
 Prism Technologies, Inc. Packaged SoftwareTechnology Services Provides ebusiness enterprise solutions | Technology Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verity Solutions Group, Inc.
 Verity Solutions Group, Inc. Packaged SoftwareTechnology Services Provides automated medication management systems to acute care hospital pharmacies | Technology Services |
Oncology, Inc.
 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides oncology treatment information | Commercial Services |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
BioIntelliSense, Inc.
BioIntelliSense, Inc. Packaged SoftwareTechnology Services Develops health monitoring and clinical intelligence for remote patient monitoring | Technology Services |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with neurodegenerative diseases | Health Technology |
Rejuveron Life Sciences AG
Rejuveron Life Sciences AG Investment ManagersFinance Functions as an alternative investment manager | Finance |
Harborpath, Inc.
Harborpath, Inc. Harborpath, Inc. is a national nonprofit healthcare organization that provides uninsured and vulnerable patients with free medications for conditions such as opioid overdose, cancer, and chronic diseases. The private company is based in Charlotte. The organization streamlines access to these drugs through a simplified, HIPAA-compliant application process, partners with pharmaceutical manufacturers, healthcare providers, states, and nonprofits, and supports communities affected by the opioid and fentanyl epidemic. Harborpath also conducts education campaigns, supplies naloxone to first responders and students, and offers oncology patient assistance programs. | |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
